Nurix Therapeutics Inc (NRIX) Ownership

23.33 ↓1.11 (-4.54%)
As of August 30, 2024, 3:59pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 6.8 million shares. Combined, the top 34 institutional holders of NRIX own 101.18% of the company with a total of 62.1 million shares.

In the latest ownership report on June 30th 2024, the top 34 institutional holders increased their combined ownership of NRIX by 12.2 million shares. 10 institutions bought 12,843,204 total additional shares and increased their ownership by an average of 158.32%. However 2 institutions sold 690,692 total shares and decreased their ownership by an average of 21.23%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc increased by a net total of 12,152,512 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.588%48.895%6,820,0152,239,6012024-06-30
Deep Track Capital, LP6.197%33.146%3,991,500993,6702024-06-30
Baker Bros Advisors LP6.027%0.000%3,882,12502024-06-30
Vanguard Group Inc5.628%40.271%3,625,0141,040,7142024-06-30
Wellington Management Company LLP4.971%1,273.390%3,201,8652,968,7292024-06-30
T. Rowe Price Associates, Inc.4.402%29.094%2,835,119638,9502024-06-30
ARK Investment Management LLC3.607%-11.839%2,323,332-312,0062024-06-30
T. Rowe Price Investment Management,Inc.3.399%0.000%2,189,1922,189,1922024-06-30
Soleus Capital Management, L.P.3.192%84.387%2,055,916940,9162024-06-30
Driehaus Capital Management LLC1.992%0.000%1,283,1081,283,1082024-06-30
Pictet Asset Manangement SA1.822%61.432%1,173,518446,5772024-06-30
Affinity Asset Advisors, LLC1.416%12.557%912,000101,7472024-06-30
Wasatch Advisors LP1.332%-30.619%858,067-378,6862024-06-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.588%48.895%6,820,0152,239,6012024-06-30
Redmile Group, LLC6.960%57.364%4,483,0161,634,1892024-03-31
Deep Track Capital, LP6.197%33.146%3,991,500993,6702024-06-30
Baker Bros Advisors LP6.027%0.000%3,882,12502024-06-30
Vanguard Group Inc5.628%40.271%3,625,0141,040,7142024-06-30
Wellington Management Company LLP4.971%1,273.390%3,201,8652,968,7292024-06-30
T. Rowe Price Associates, Inc.4.402%29.094%2,835,119638,9502024-06-30
Wasatch Advisors Inc.5.624%-22.860%2,749,745-814,8712023-12-31
State Street Corporation4.237%196.241%2,729,3361,808,0142024-03-31
Morgan Stanley - Brokerage Accounts3.929%-19.274%2,530,799-604,2382024-03-31
ARK Investment Management LLC3.607%-11.839%2,323,332-312,0062024-06-30
T. Rowe Price Investment Management,Inc.3.399%0.000%2,189,1922,189,1922024-06-30
Soleus Capital Management, L.P.3.192%84.387%2,055,916940,9162024-06-30
TRV GP III, LLC4.078%0.000%1,922,54902022-06-30
Deutsche Bank AG2.328%197.373%1,499,368995,1632024-03-31
Driehaus Capital Management LLC1.992%0.000%1,283,1081,283,1082024-06-30
Boxer Capital LLC2.505%0.000%1,224,89202023-09-30
Pictet Asset Manangement SA1.822%61.432%1,173,518446,5772024-06-30
Bain Capital Life Sciences Investors, LLC1.758%-37.879%1,132,397-690,4862024-03-31
Geode Capital Management, LLC1.708%1.834%1,100,33519,8122024-03-31
Dimensional Fund Advisors, Inc.1.500%-3.359%966,453-33,5912024-03-31
Affinity Asset Advisors, LLC1.416%12.557%912,000101,7472024-06-30
Candriam Luxembourg S.C.A.1.385%-2.832%892,110-26,0002024-03-31
Wasatch Advisors LP1.332%-30.619%858,067-378,6862024-06-30
TCG Crossover Management, LLC1.175%0.000%717,654717,6542023-12-31
Foresite Capital Management IV, LLC1.436%-34.309%677,143-353,6552022-06-30
Millennium Management LLC1.329%39.606%644,411182,8192023-06-30
Charles Schwab Investment Management Inc0.997%3.197%642,19019,8932024-03-31
Dafna Capital Management LLC1.139%0.000%556,69502023-09-30
Bank of America Corp1.118%-7.070%546,450-41,5752023-09-30
Nuveen Asset Management, LLC0.874%-19.509%533,865-129,3952023-12-31
Goldman Sachs Group Inc0.765%-12.617%492,666-71,1342024-03-31
Northern Trust Corp0.902%2.849%440,85212,2102023-09-30
FMR Inc0.859%-53.735%416,613-483,8752023-06-30

Mutual Fund Ownership

ARK Genomic Revolution is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 2.3 million shares. Combined, the top 36 mutual fund holders of NRIX own 49.36% of the company with a total of 29.2 million shares.

In the latest ownership report on July 31st 2024, the top 36 fund holders increased their combined ownership of NRIX by 80 thousand shares. 5 funds bought 83,594 total additional shares and increased their ownership by an average of 1.65%. However 1 funds sold 3,537 total shares and decreased their ownership by an average of 0.83%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc increased by a net total of 80,057 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF3.565%0.556%2,296,39612,6902024-07-31
Vanguard Total Stock Mkt Idx Inv2.952%0.000%1,901,52502024-07-31
iShares Russell 2000 ETF2.581%1.192%1,662,46419,5782024-07-31
SPDR® S&P Biotech ETF2.271%0.445%1,463,0246,4822024-07-31
Vanguard Institutional Extnd Mkt Idx Tr1.321%0.573%850,6244,8442024-07-31
Belfius Equities Cure C Cap1.191%5.501%767,09640,0002024-07-31
BlackRock Health Sciences Opps Inv A0.962%0.000%619,55702024-07-31
Xtrackers MSCI World Swap ETF 1C0.835%0.000%537,68002024-07-31
iShares Biotechnology ETF0.652%-0.835%420,170-3,5372024-07-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution3.565%-12.017%2,296,396-313,6592024-06-30
ARK Genomic Revolution ETF3.565%0.556%2,296,39612,6902024-07-31
Vanguard Total Stock Mkt Idx Inv2.952%0.000%1,901,52502024-07-31
iShares Russell 2000 ETF2.581%1.192%1,662,46419,5782024-07-31
Vanguard Instl Ttl Stck Mkt Idx Tr3.240%29.436%1,571,546357,4002023-03-31
SPDR® S&P Biotech ETF2.271%0.445%1,463,0246,4822024-07-31
T. Rowe Price New Horizons2.264%27.862%1,458,535317,8252024-06-30
US Small-Cap Growth II Equity Comp2.264%27.862%1,458,535317,8252024-06-30
Eventide Healthcare & Life Sciences I2.448%-38.289%1,154,000-716,0002022-06-30
Wasatch Small Cap Growth Investor1.852%-2.514%898,101-23,1602023-09-30
Vanguard Institutional Extnd Mkt Idx Tr1.321%0.573%850,6244,8442024-07-31
Belfius Equities Cure C Cap1.191%5.501%767,09640,0002024-07-31
Candriam Global Equities Oncology1.129%35.375%727,096190,0002024-06-30
Wasatch Small Cap Value1.430%29.273%702,910159,1682023-12-31
BlackRock Health Sciences Opps Inv A0.962%0.000%619,55702024-07-31
Vanguard Extended Market Index Investor1.278%-0.029%616,077-1812023-08-31
T. Rowe Price Small-Cap Value0.956%0.000%615,995615,9952024-06-30
UBS: US Equity Small Cap Growth1.205%0.000%589,17602023-09-30
Wasatch Ultra Growth0.852%-37.048%548,977-323,0752024-06-30
Xtrackers MSCI World Swap ETF 1C0.835%0.000%537,68002024-07-31
Nuveen Quant Small Cap Equity R60.812%0.000%523,10002024-06-30
TIAA-CREF Quant Small-Cap Equity Instl1.026%20.000%501,61083,6002024-01-31
Xtrackers S&P Global Infra Swap ETF 1C0.751%0.000%483,68802023-12-31
Fidelity Small Cap Index0.740%0.764%476,6463,6122024-05-31
Fidelity® Small Cap Index0.940%1.146%456,1115,1682023-10-31
Candriam Eqs L Biotech C USD Cap0.679%0.000%437,10702024-06-30
iShares Russell 2000 Value ETF0.706%-0.133%431,115-5722024-05-30
iShares Biotechnology ETF0.652%-0.835%420,170-3,5372024-07-31
Pictet-Biotech P USD0.629%0.274%404,9211,1052024-04-30
BlackRock Health Sciences Term Trust0.601%0.000%387,01602024-05-31
Fidelity® Select Biotechnology0.756%0.000%366,64602023-08-31
Pictet-Global Megatrend Sel I USD0.741%5.347%364,18518,4832023-12-31
Wasatch Micro Cap0.717%27.338%352,48275,6732023-12-31
Nuveen Quant Small Cap Equity Instl0.501%-38.987%306,050-195,5602024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.482%0.000%294,51302024-04-30
Schwab Small-Cap Equity0.467%6.284%284,88916,8432024-03-31

Discussions

Please log in or register to share your thoughts.